Results of an Ingress Real World Observational Study in neovascular age-related macular degeneration (nAMD) published!
Ingress-Health brought its contribution in a recent publication in the acknowledged scientific journal RETINA. In this publication, the real-world treatment of German nAMD patients as well as deficiencies in the real-world care were analyzed. The authors concluded that shortcomings in the timely and adequate follow-up after initiation of an intravitreal injection therapy are the main explanation for real-world treatment outcomes that are worse than those known from clinical studies.
The manuscript is available here.
For more details, please contact Sabrina Mueller (firstname.lastname@example.org)